Corporate Banner
Satellite Banner
Technology Networks Header
Monday, April 21, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Oklahoma Acquires New Imaging Technology
Thursday, September 05, 2013
Protea Biosciences have announced that the University of Oklahoma’s Institute for Natural Products Applications and Research Technologies (INPART) has acquired the LAESI DP1000 biomolecular imaging system.

Epicentre’s New Ribo-Zero™ Magnetic Gold and ScriptSeq™ Complete Gold Kits
Monday, September 02, 2013
Cambio now supplies Epicentre’s new kits for yeast rRNA extraction.

Illumina Launches New Reagent Kits for the MiSeq® System
Thursday, August 22, 2013
Latest milestone doubles sequencing output to 15Gb, enables applications including exome sequencing.

Roche Launches GS FLX+ System Software Update
Wednesday, August 07, 2013
The latest software version 2.9 enables highly accurate sequencing of long 16S ribosomal RNA amplicons for more precise taxonomic assignment of organisms in microbial surveys.

Thermo Fisher Scientific Expands Water Purification Portfolio
Thursday, August 01, 2013
Advanced dispensing technology increases flexibility and ease-of-use for shared lab environments.

OGT to Launch New Cancer Focused CytoSure™ Array at CCMC Meeting
Tuesday, July 30, 2013
Reliable CCMC-standardised array for CNV and LOH detection in haematological malignancies and solid tumours.

Bio-Rad Introduces the QX200 Droplet Digital PCR System
Monday, July 29, 2013
Bio-Rad Laboratories, Inc. announced the launch of its QX200 Droplet Digital™ PCR (ddPCR) system, the second generation of the company's Droplet Digital™ PCR technology.

Plexpress Launches Dedicated Canine ADME-Tox Service
Friday, July 05, 2013
TRACPACK DOG INDUCTION for preclinical drug candidate screening.

Exiqon Launches LNA™ microRNA Target Site Blockers
Friday, June 28, 2013
Efficient and specific blocking of microRNA binding.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 614
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv